This advert is not available!
The Department of Oncology and Pathology’s mission is to improve diagnostics, treatment and quality of life for patients with cancer through basic, translational and clinical research and education in the field of cancer. We want to achieve excellence in research and education, foster clinical research and create high technology platforms for research support and innovation. In that we value ethics, high diversity and equality; cultivate openness networking and collaborations to consolidate national and international forces to cure cancer.
Our research focuses on the development of radiopharmaceuticals for precision diagnostics, therapy and monitoring of cancer diseases, so called theranostics.
We conduct studies including cyclotron production of radiometals using solid target, novel radiopharmaceutical developments, biological evaluation studies in vitro and in vivo using different cancer models, to clinical translation. In close collaborations with oncologists and radiologists, we perform several clinical studies (first-in-human, phase I/II studies) of different radiopharmaceuticals.
The radiopharmaceuticals we develop for diagnostics are labelled with radiometals for PET (positron emission tomography) imaging while for therapeutic applications, they will be labelled with alpha or beta emitters.
We are now looking for a driven, curious individual who wants to contribute to the development of small-peptide and monoclonal antibody-based radiopharmaceuticals for improving diagnostics and therapy effects of metastatic cancer diseases. The work will include radiolabelling, quality control using analytical methods such as HPLC and TLC, in vitro cell binding assays and animal studies.
We are looking for someone with a MSc degree in applied life sciences such as Radiopharmacy, Pharmacy, Drug Development, Biomedicine, Biology or equivalent.
Who are you?
In this recruitment we put high preference on personal suitability.
A creative and inspiring environment with wide-ranging expertise and interests. Karolinska Institutet is one of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. Karolinska Institutet is also a state university, which entitles you to several good benefits through our collective agreement. And you get to practice freely in our modern wellness facilities, where trained staff are on site.
Location: BioClinicum, Solna
Choose to work at KI – Ten reasons why
Welcome to apply at the latest December 31st.
The application is to be submitted through the Varbi recruitment system.In this recruitment, you will apply with your CV without a personal letter. Instead, you will answer some questions about why you are applying for the job in the application form.
Type of employment | Special fixed-term employment |
---|---|
Contract type | Full time |
First day of employment | Upon agreement, but no later than the end of January 2023 |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Solna |
County | Stockholms län |
Country | Sweden |
Reference number | STÖD 2-4981/2022 |
Contact |
|
Published | 12.Dec.2022 |
Last application date | 31.Dec.2022 11:59 PM CET |